Rita Karamy

Rita Karamy is an experienced professional in market access and health economics, with a robust background in strategic roles within the pharmaceutical industry. At AstraZeneca from November 2017 to September 2022, Rita served as Senior Portfolio Manager for Market Access and led the international market access strategy for biologics, while also managing pricing strategies and health economic assessments. Prior experience includes consulting on health economics and outcomes research at Optum and coordinating clinical networks at Novartis Pharmaceuticals. Rita holds a degree in Health Economics & Policy from Monash University and a Bachelor of Pharmacy from the University of Sydney.